Notable Acquisitions in Health Diagnostics

26/02/2020
Diego Gutiérrez
Notable Acquisitions in Health Diagnostics

The health diagnostics sector includes all those companies dedicated to the development of techniques and instruments that facilitate the early diagnosis of pathologies and/or diseases and enable action to be taken against them as soon as possible.

Technological progress, the application of artificial intelligence in medicine and the rise of biotechnology have enabled strong growth in the sector. health diagnostics in recent years.

Since 2010, more than 1,500 companies have been created and around $13 billion in funding has been raised. Moreover, since 2018, growth has accelerated, raising almost $6 billion in some 300 funding rounds in just one year.

Notable acquisitions at Health Diagnostics

Health Diagnostics

Most recent investments

One of the most relevant operations of 2019 at the global level was that of Tangen Bioscienceswhich launched its second round (Round B) of fundraising for a total value of $75 million. Another important launch of 2019 was that of Zava, the medical and pharmaceutical services brand, which raised $32 million in its first round (Round A). In addition, gut health specialist Cara Care raised $26.4 million in its second round of funding.

The most active investors in the A and B rounds in health diagnostics were the Novartis Venture Funds, F-Prime Capital and the Singaporean investment company Temasek Holdings.

The most active investors in the A and B rounds in health diagnostics have been the funds Novartis Venture, F- Prime Capital and Singaporean investment company Temasek Holdings.

Major acquisitions

One of the mergers and acquisitions The most significant acquisition in recent years was that of Envision Healthcare by the well-known US investment firm Kohlberg Kravis Roberts (KKR) for $750 million in June 2018.

The pharmaceutical company Roche acquired in February 2018 Flatiron Healtha company dedicated to the research and development of cancer solutions. 

The most important acquisition in 2019 was the acquisition of the pharmaceutical company Nightstar Therapeutics for Biogen. The deal was valued at $174.6 million.

Lastest news

Webinar | Cómo maximizar el valor de tu empresa antes de vender

INFORMACIÓN IMPORTANTE: La inscripción y participación en los webinars es totalmente anónima para terceros Cómo maximizar el valor de tu empresa antes de vender Maximizar el valor de tu empresa antes de vender es, casi siempre, el trabajo más rentable que puede hacer...

The State of technology M&A in Spain | May 2026 Analysis

El M&A tecnológico en España registró en mayo de 2026 36 operaciones identificadas con un importe agregado conocido de aproximadamente 720,7 millones de euros. La cifra es una referencia mínima: 13 transacciones no hicieron público su importe. El mes combinó...

Notable technology M&A deals in Spain | Analysis: April 2026

The market for the sale and acquisition of technology companies in Spain once again saw particularly brisk activity in April 2026. The month saw significant deals in vertical software, cybersecurity, cloud computing, payments, artificial intelligence, telecommunications...

What does Constellation Software teach us about real value in tech M&A?

An analysis by Diego Gutiérrez Zarza, Partner at Baker Tilly Tech M&A For years, growth was enough to build value in a technology company. That is no longer the case. The market continues to pay a premium for good software companies, but it no longer rewards growth for its own sake...

Strategic Guide: AI and Valuation Multiples in Tech M&A in 2026

An analysis by Diego Gutiérrez Zarza, Partner at Baker Tilly Tech M&A To help you understand the current market for buying and selling technology companies, we have summarised the key points of our latest research in this quick-reference guide. How are...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42